Literature DB >> 23278719

Chemokine programming dendritic cell antigen response: part I - select chemokine programming of antigen uptake even after maturation.

Jaehyung Park1, Cindy T Wu, James D Bryers.   

Abstract

Here, we report on the successful programming of dendritic cells (DCs) using selectively applied mixtures of chemokines as a novel protocol for engineering vaccine efficiency. Antigen internalization by DCs is a pivotal step in antigen uptake/presentation for bridging innate and adaptive immunity and in exogenous gene delivery used in vaccine strategies. Contrary to most approaches to improve vaccine efficiency, active enhancement of antigen internalization by DCs as a vaccine strategy has been less studied because DCs naturally down-regulate antigen internalization upon maturation. Whereas chemokines are mainly known as signal proteins that induce leucocyte chemotaxis, very little research has been carried out to identify any additional effects of chemokines on DCs following maturation. Here, immature DCs are pre-treated with select chemokines before intentional maturation using lipopolysaccharide (LPS). When pre-treated with a mixture of CCL3 and CCL19 in a 7 : 3 ratio, then matured with LPS, chemokine pre-treated DCs exhibited 36% higher antigen uptake capacity than immature DCs and 27% higher antigen-processing capacity than immature DCs treated only with LPS. Further, CCL3 : CCL19 (7 : 3) pre-treatment of DCs modulated MHC molecule expression and secretion of various cytokines of DCs. Collectively, DC programming was feasible using a specific chemokine combination and these results provide a novel strategy for enhancing DC-based vaccine efficiency. In Part II, we report on the phenotype changes and antigen presentation capacity of chemokine pre-treated murine bone marrow-derived DCs examined in long-term co-culture with antigen-specific CD4(+) T cells.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23278719      PMCID: PMC3634540          DOI: 10.1111/imm.12056

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  67 in total

1.  Sustained GM-CSF and PEI condensed pDNA presentation increases the level and duration of gene expression in dendritic cells.

Authors:  Omar A Ali; David J Mooney
Journal:  J Control Release       Date:  2008-07-10       Impact factor: 9.776

Review 2.  Materials engineering for immunomodulation.

Authors:  Jeffrey A Hubbell; Susan N Thomas; Melody A Swartz
Journal:  Nature       Date:  2009-11-26       Impact factor: 49.962

3.  Adrenomedullin, a neuropeptide with immunoregulatory properties induces semi-mature tolerogenic dendritic cells.

Authors:  Sandrine Rullé; Marie-Dominique Ah Kioon; Carine Asensio; Julie Mussard; Hang-Korng Ea; Marie-Christophe Boissier; Frédéric Lioté; Géraldine Falgarone
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

4.  Combination of IL-17 and TNFα induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells.

Authors:  Arnaud Hot; Vanina Lenief; Pierre Miossec
Journal:  Ann Rheum Dis       Date:  2012-01-18       Impact factor: 19.103

5.  Induction of allogeneic mixed chimerism by immature dendritic cells and bone marrow transplantation leads to prolonged tolerance to major histocompatibility complex disparate allografts.

Authors:  Ping Yu; Sidong Xiong; Qiuzao He; Yiwei Chu; Chi Lu; Charmaine A Ramlogan; Jason C Steel
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

Review 6.  Plasmid DNA- and messenger RNA-based anti-cancer vaccination.

Authors:  Benjamin Weide; Claus Garbe; Hans-Georg Rammensee; Steve Pascolo
Journal:  Immunol Lett       Date:  2007-10-26       Impact factor: 3.685

7.  A protective vaccine delivery system for in vivo T cell stimulation using nanoengineered polymer hydrogel capsules.

Authors:  Amy Sexton; Paul G Whitney; Siow-Feng Chong; Alexander N Zelikin; Angus P R Johnston; Robert De Rose; Andrew G Brooks; Frank Caruso; Stephen J Kent
Journal:  ACS Nano       Date:  2009-11-24       Impact factor: 15.881

8.  Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.

Authors:  Caroline E Sutton; Stephen J Lalor; Cheryl M Sweeney; Corinna F Brereton; Ed C Lavelle; Kingston H G Mills
Journal:  Immunity       Date:  2009-08-13       Impact factor: 31.745

9.  Infection-mimicking materials to program dendritic cells in situ.

Authors:  Omar A Ali; Nathaniel Huebsch; Lan Cao; Glenn Dranoff; David J Mooney
Journal:  Nat Mater       Date:  2009-01-11       Impact factor: 43.841

10.  TLR ligand-induced podosome disassembly in dendritic cells is ADAM17 dependent.

Authors:  Michele A West; Alan R Prescott; Kui Ming Chan; Zhongjun Zhou; Stefan Rose-John; Jürgen Scheller; Colin Watts
Journal:  J Cell Biol       Date:  2008-09-01       Impact factor: 10.539

View more
  2 in total

1.  Chemokine programming dendritic cell antigen response: part II - programming antigen presentation to T lymphocytes by partially maintaining immature dendritic cell phenotype.

Authors:  Jaehyung Park; James D Bryers
Journal:  Immunology       Date:  2013-05       Impact factor: 7.397

2.  CCL3 Enhances Antitumor Immune Priming in the Lymph Node via IFNγ with Dependency on Natural Killer Cells.

Authors:  Frederick Allen; Peter Rauhe; David Askew; Alexander A Tong; Joseph Nthale; Saada Eid; Jay T Myers; Caryn Tong; Alex Y Huang
Journal:  Front Immunol       Date:  2017-10-23       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.